◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › HUM

Humana Inc (HUM) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Managed Health Care · DATA UPDATED 2026-07-14

Humana Inc (HUM) operates in the Managed Health Care industry and is headquartered in Louisville, United States with about 67,060 employees. Its market capitalization is roughly $47 billion. In the fiscal year ended 2025-12-31, HUM reported $129.7B in revenue and $1.2B in net income.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.

Interactive charts & full statements → Open the HUM valuation workbench →

HUM Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$137.2B$129.7B$117.8B$106.4B$92.9B$83.6B$77.2B$64.9B$56.9B$53.8B$54.4B$54.3B$48.5B$41.3B$39.1B$36.8B$33.9B$31.0B$29.0B$25.3B$21.4B
Gross Profit$19.2B$18.9B$17.1B$18.0B$17.2B$14.4B$15.7B$11.2B$11.2B$7.1B$7.8B$7.8B$8.0B$6.7B$6.1B$5.7B$4.8B$4.5B$4.2B$3.7B$3.2B
Gross Margin %14.0%14.5%14.5%17.0%18.5%17.3%20.3%17.2%19.7%13.2%14.3%14.3%16.4%16.2%15.7%15.4%14.1%14.5%14.3%14.5%14.8%
Operating Income (EBIT)$1.4B$1.5B$1.6B$3.3B$3.6B$3.4B$4.7B$3.5B$2.1B$3.3B$1.7B$2.3B$2.4B$2.1B$2.1B$2.3B$2.0B$1.7B$1.2B$1.4B$825M
Operating Margin %1.0%1.1%1.4%3.1%3.8%4.1%6.1%5.3%3.6%6.2%3.2%4.3%4.9%5.0%5.3%6.4%6.0%5.5%4.0%5.4%3.9%
Net Income$1.1B$1.2B$1.2B$2.5B$2.8B$2.9B$3.4B$2.7B$1.7B$2.4B$614M$1.3B$1.1B$1.2B$1.2B$1.4B$1.1B$1.0B$647M$834M$487M
Net Margin %0.8%0.9%1.0%2.3%3.0%3.5%4.4%4.2%3.0%4.5%1.1%2.4%2.4%3.0%3.1%3.9%3.2%3.4%2.2%3.3%2.3%
EBITDA$2.9B$2.9B$3.3B$4.7B$4.8B$4.5B$5.6B$4.3B$2.8B($936M)$2.2B($270M)$2.8B$2.5B$46M$2.6B$162M$2.0B$103M$1.5B$974M
Earnings Per Share (EPS)$9.34$9.83$9.99$20.00$22.08$22.67$25.31$20.09$12.16$16.81$4.07$8.44$7.36$7.73$7.48$8.46$6.47$6.15$3.83$4.91$2.90
Shares Outstanding (M)121M121M121M124M127M129M133M135M138M146M151M151M156M159M163M168M170M169M169M170M168M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HUM Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$39.6B$32.5B$32.6B$32.4B$32.1B$29.2B$29.4B$29.5B
Gross Profit$5.9B$3.8B$4.7B$4.8B$5.6B$3.8B$4.3B$4.5B
Gross Margin %15.0%11.7%14.3%14.9%17.4%13.1%14.5%15.2%
Operating Income (EBIT)$1.6B($1.0B)$108M$722M$1.6B($899M)$635M$901M
Operating Margin %4.0%-3.1%0.3%2.2%5.1%-3.1%2.2%3.0%
Net Income$1.2B($796M)$195M$545M$1.2B($693M)$480M$679M
Net Margin %3.0%-2.5%0.6%1.7%3.9%-2.4%1.6%2.3%
EBITDA$2.0B($685M)$480M$1.1B$2.0B($495M)$1.0B$1.3B
Earnings Per Share (EPS)$9.83$-6.61$1.61$4.51$10.30$-5.74$3.97$5.63
Shares Outstanding (M)121M120M121M121M121M121M121M121M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HUM Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$1.8B$921M$3.0B$4.0B$4.6B$2.3B$5.6B$5.3B$2.2B$4.1B$1.9B$868M$1.6B$1.7B$1.9B$2.1B$2.2B$1.4B$982M$1.2B$1.7B
Capital Expenditures (CapEx)$572M$546M$575M$1.0B$1.1B$1.3B$964M$736M$612M$526M$527M$523M$528M$437M$410M$336M$222M$185M$262M$239M$193M
Free Cash Flow (FCF)$1.3B$375M$2.4B$3.0B$3.5B$946M$4.7B$4.5B$1.6B$3.5B$1.4B$345M$1.1B$1.3B$1.5B$1.7B$2.0B$1.2B$721M$985M$1.5B
FCF Margin %0.9%0.3%2.0%2.8%3.7%1.1%6.1%7.0%2.7%6.6%2.6%0.6%2.2%3.1%3.9%4.7%6.0%4.0%2.5%3.9%7.0%
Dividends Paid$429M$430M$431M$431M$392M$354M$323M$291M$265M$220M$177M$172M$172M$168M$165M$82M$0M$0M$2.4B$95M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HUM Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$1.3B($1.7B)$971M$1.3B$331M($528M)$1.9B$1.2B
Capital Expenditures (CapEx)$121M$202M$135M$114M$95M$154M$130M$114M
Free Cash Flow (FCF)$1.1B($1.9B)$836M$1.2B$236M($682M)$1.7B$1.1B
FCF Margin %2.9%-5.7%2.6%3.6%0.7%-2.3%5.9%3.7%
Dividends Paid$107M$109M$107M$106M$108M$108M$107M$107M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HUM Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$55.3B$48.8B$46.3B$46.9B$43.7B$44.7B$35.1B$29.0B$25.3B$26.7B$25.8B$25.1B$23.4B$20.8B$19.5B$17.9B$16.1B$14.2B$13.0B$12.9B$10.1B
Cash & Cash Equivalents$5.0B$4.2B$2.2B$4.7B$5.1B$3.4B$4.7B$4.1B$2.3B$4.0B$3.9B$2.6B$1.9B$1.1B$1.3B$1.4B$1.7B$1.6B$2.0B$2.0B$1.7B
Total Liabilities$36.6B$31.0B$29.9B$30.6B$28.4B$28.6B$21.3B$17.0B$15.2B$16.8B$15.1B$14.8B$13.8B$11.5B$10.7B$9.8B$9.1B$8.4B$8.6B$8.8B$7.1B
Total Debt (Short + Long-Term)$14.0B$12.5B$11.9B$11.8B$11.3B$12.7B$6.8B$5.8B$6.1B$4.9B$4.4B$4.1B$4.2B$3.0B$2.9B$2.0B$1.7B$2.1B$2.2B$2.0B$1.6B
Total Shareholders' Equity$18.6B$17.7B$16.4B$16.3B$15.3B$16.1B$13.7B$12.0B$10.2B$9.8B$10.7B$10.3B$9.6B$9.3B$8.8B$8.1B$6.9B$5.8B$4.5B$4.0B$3.1B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HUM viewer.

Other Companies in Managed Health Care

← HUHUAll stocksHUMA →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.